Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1, and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3.

Sakane T, Murase T, Okuda K, Saida K, Masaki A, Yamada T, Saito Y, Nakanishi R, Inagaki H.

Histopathology. 2019 Jun 10. doi: 10.1111/his.13936. [Epub ahead of print]

PMID:
31179560
2.

Safe resection margin in video-assisted left anterior and lingular segmentectomy for an impalpable lung nodule.

Mizuno K, Sakane T.

Int J Surg Case Rep. 2019;59:7-10. doi: 10.1016/j.ijscr.2019.04.048. Epub 2019 May 7.

3.

Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats.

Alama T, Kusamori K, Morishita M, Katsumi H, Sakane T, Yamamoto A.

Pharmaceutics. 2019 Apr 7;11(4). pii: E170. doi: 10.3390/pharmaceutics11040170.

4.

Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak.

Watanabe T, Fukai I, Okuda K, Moriyama S, Haneda H, Kawano O, Yokota K, Shitara M, Tatematsu T, Sakane T, Oda R, Nakanishi R.

J Thorac Dis. 2019 Jan;11(1):171-176. doi: 10.21037/jtd.2018.12.85.

5.

Computer-assisted detection of metastatic lung tumors on computed tomography.

Yoshida Y, Sakane T, Isogai J, Suzuki Y, Miki S, Nomura Y, Nakajima J.

Asian Cardiovasc Thorac Ann. 2019 Mar;27(3):199-207. doi: 10.1177/0218492319831836.

PMID:
30789307
6.

Hepatic and Intrahepatic Targeting of Hydrogen Sulfide Prodrug by Bioconjugation.

Sakai K, Katsumi H, Kamano K, Yamauchi K, Hajima A, Morishita M, Sakane T, Yamamoto A.

Biol Pharm Bull. 2019;42(2):273-279. doi: 10.1248/bpb.b18-00773.

7.

Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism.

Kimura S, Kiriyama A, Nishimura E, Sakata S, Inoue D, Furubayashi T, Yutani R, Tanaka A, Kusamori K, Katsumi H, Iga K, Yamamoto A, Sakane T.

Biol Pharm Bull. 2018;41(12):1769-1777. doi: 10.1248/bpb.b18-00315.

8.

l-Cysteine and l-Serine Modified Dendrimer with Multiple Reduced Thiols as a Kidney-Targeting Reactive Oxygen Species Scavenger to Prevent Renal Ischemia/Reperfusion Injury.

Matsuura S, Katsumi H, Suzuki H, Hirai N, Takashima R, Morishita M, Sakane T, Yamamoto A.

Pharmaceutics. 2018 Dec 1;10(4). pii: E251. doi: 10.3390/pharmaceutics10040251.

9.

Long-term outcomes of video-assisted thoracoscopic surgery lobectomy vs. thoracotomy lobectomy for stage IA non-small cell lung cancer.

Oda R, Okuda K, Osaga S, Watanabe T, Sakane T, Tatematsu T, Yokota K, Haneda H, Nakanishi R.

Surg Today. 2019 May;49(5):369-377. doi: 10.1007/s00595-018-1746-4. Epub 2018 Dec 3.

PMID:
30511319
10.

Thymic inflammatory pseudotumor with multilocular thymic cyst caused by immunoglobulin G4-related disease.

Oda R, Okuda K, Murase T, Watanabe T, Sakane T, Tatematsu T, Yokota K, Haneda H, Nakanishi R.

Thorac Cancer. 2019 Jan;10(1):116-119. doi: 10.1111/1759-7714.12914. Epub 2018 Nov 23.

11.

Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34).

Naito C, Katsumi H, Suzuki T, Quan YS, Kamiyama F, Sakane T, Yamamoto A.

Pharmaceutics. 2018 Nov 4;10(4). pii: E215. doi: 10.3390/pharmaceutics10040215.

12.

Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.

Sawangrat K, Yamashita S, Tanaka A, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

J Pharm Sci. 2019 Mar;108(3):1315-1325. doi: 10.1016/j.xphs.2018.10.043. Epub 2018 Oct 30.

PMID:
30389568
13.

l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier.

Matsuura S, Katsumi H, Suzuki H, Hirai N, Hayashi H, Koshino K, Higuchi T, Yagi Y, Kimura H, Sakane T, Yamamoto A.

Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10511-10516. doi: 10.1073/pnas.1808168115. Epub 2018 Sep 24.

14.

Pure red cell aplasia associated with thymoma: a report of a single-center experience.

Moriyama S, Yano M, Haneda H, Okuda K, Kawano O, Sakane T, Oda R, Watanabe T, Nakanishi R.

J Thorac Dis. 2018 Aug;10(8):5066-5072. doi: 10.21037/jtd.2018.07.14.

15.

Utility of Solid-State UV/Vis Spectra on the Evaluation of Photostability of Indomethacin Crystals.

Kiguchiya A, Teraoka R, Sakane T.

Chem Pharm Bull (Tokyo). 2018;66(9):892-895. doi: 10.1248/cpb.c18-00389.

16.

Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.

Inoue D, Kimura S, Kiriyama A, Katsumi H, Yamamoto A, Ogawara KI, Higaki K, Tanaka A, Yutani R, Sakane T, Furubayashi T.

Mol Pharm. 2018 Oct 1;15(10):4462-4469. doi: 10.1021/acs.molpharmaceut.8b00464. Epub 2018 Sep 17.

PMID:
30165013
17.

Pharmacokinetics and Preventive Effects of Sulfo-Albumin as a Novel Macromolecular Hydrogen Sulfide Prodrug on Carbon Tetrachloride-Induced Hepatic Injury.

Sakai K, Katsumi H, Sugiura M, Tamba A, Kamano K, Yamauchi K, Tamura Y, Sakane T, Yamamoto A.

J Pharm Sci. 2018 Oct;107(10):2686-2693. doi: 10.1016/j.xphs.2018.06.022. Epub 2018 Jul 2.

PMID:
30156185
18.

Blastomatoid pulmonary carcinosarcoma: A rare case report and review of the literature.

Sakane T, Okuda K, Hattori H, Watanabe T, Oda R, Tatematsu T, Yokota K, Haneda H, Inagaki H, Nakanishi R.

Thorac Cancer. 2018 Oct;9(10):1323-1326. doi: 10.1111/1759-7714.12831. Epub 2018 Aug 14. Review.

19.

Intranasal rifampicin for Alzheimer's disease prevention.

Umeda T, Tanaka A, Sakai A, Yamamoto A, Sakane T, Tomiyama T.

Alzheimers Dement (N Y). 2018 Jul 14;4:304-313. doi: 10.1016/j.trci.2018.06.012. eCollection 2018.

20.

Effects of Various Pharmaceutical Excipients on the Intestinal Transport and Absorption of Sulfasalazine, a Typical Substrate of Breast Cancer Resistance Protein Transporter.

Sawangrat K, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

J Pharm Sci. 2018 Nov;107(11):2946-2956. doi: 10.1016/j.xphs.2018.07.011. Epub 2018 Jul 25.

PMID:
30053556
21.

The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancer.

Okuda K, Tatematsu T, Yano M, Nakamae K, Yamada T, Kasugai T, Nishida T, Sano M, Moriyama S, Haneda H, Kawano O, Sakane T, Oda R, Watanabe T, Nakanishi R.

Mol Clin Oncol. 2018 Jul;9(1):21-29. doi: 10.3892/mco.2018.1619. Epub 2018 May 4.

22.

Thymothymectomy with pulmonary partial resection using the subxiphoid approach: how to do it?

Okuda K, Haneda H, Yokota K, Tatematsu T, Sakane T, Oda R, Watanabe T, Nakanishi R.

Surg Today. 2018 Dec;48(12):1096-1099. doi: 10.1007/s00595-018-1686-z. Epub 2018 Jun 22.

PMID:
29934685
23.

Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma.

Watanabe T, Okuda K, Murase T, Moriyama S, Haneda H, Kawano O, Yokota K, Sakane T, Oda R, Inagaki H, Nakanishi R.

Oncotarget. 2018 Apr 17;9(29):20769-20780. doi: 10.18632/oncotarget.25100. eCollection 2018 Apr 17.

24.

The outcomes of anatomical lung resection for nontuberculous mycobacterial lung disease.

Sakane T, Matsuoka K, Kumata S, Watanabe R, Yamada T, Matsuoka T, Nagai S, Ueda M, Miyamoto Y.

J Thorac Dis. 2018 Feb;10(2):954-962. doi: 10.21037/jtd.2018.01.60.

25.

Erratum to 'Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement' [Int. J. Pharm. 2018, 535, 340-349].

Li X, Uehara S, Sawangrat K, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Int J Pharm. 2018 Apr 25;541(1-2):261. doi: 10.1016/j.ijpharm.2018.03.003. No abstract available.

PMID:
29578413
26.

A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma.

Sakane T, Murase T, Okuda K, Takino H, Masaki A, Oda R, Watanabe T, Kawano O, Haneda H, Moriyama S, Saito Y, Yamada T, Nakanishi R, Inagaki H.

Oncotarget. 2018 Jan 8;9(6):6993-7009. doi: 10.18632/oncotarget.24075. eCollection 2018 Jan 23.

27.

Regulation of proliferation and functioning of transplanted cells by using herpes simplex virus thymidine kinase gene in mice.

Tsujimura M, Kusamori K, Oda C, Miyazaki A, Katsumi H, Sakane T, Nishikawa M, Yamamoto A.

J Control Release. 2018 Apr 10;275:78-84. doi: 10.1016/j.jconrel.2018.02.018. Epub 2018 Feb 16.

PMID:
29458052
28.

The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption.

Inoue D, Tanaka A, Kimura S, Kiriyama A, Katsumi H, Yamamoto A, Ogawara KI, Kimura T, Higaki K, Yutani R, Sakane T, Furubayashi T.

Eur J Pharm Sci. 2018 May 30;117:21-26. doi: 10.1016/j.ejps.2018.01.032. Epub 2018 Feb 2.

PMID:
29410273
29.

Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis.

Yamashita S, Katsumi H, Sakane T, Yamamoto A.

J Drug Target. 2018 Nov;26(9):818-828. doi: 10.1080/1061186X.2018.1434659. Epub 2018 Feb 6.

PMID:
29376757
30.

Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.

Tanaka A, Furubayashi T, Arai M, Inoue D, Kimura S, Kiriyama A, Kusamori K, Katsumi H, Yutani R, Sakane T, Yamamoto A.

Mol Pharm. 2018 Mar 5;15(3):1105-1111. doi: 10.1021/acs.molpharmaceut.7b00991. Epub 2018 Jan 30.

PMID:
29338251
31.

Pulmonary inflammatory myofibroblastic tumor with TPM4-ALK translocation.

Okuda K, Watanabe T, Oda R, Sakane T, Kawano O, Haneda H, Moriyama S, Nakanishi R.

J Thorac Dis. 2017 Nov;9(11):E1013-E1017. doi: 10.21037/jtd.2017.10.103.

32.

Recent advances in video-assisted transthoracic tracheal resection followed by reconstruction under non-intubated anesthesia with spontaneous breathing.

Okuda K, Moriyama S, Haneda H, Kawano O, Sakane T, Oda R, Watanabe T, Nakanishi R.

J Thorac Dis. 2017 Sep;9(9):2891-2894. doi: 10.21037/jtd.2017.08.58. No abstract available.

33.

Long-term drug modification to the surface of mesenchymal stem cells by the avidin-biotin complex method.

Takayama Y, Kusamori K, Hayashi M, Tanabe N, Matsuura S, Tsujimura M, Katsumi H, Sakane T, Nishikawa M, Yamamoto A.

Sci Rep. 2017 Dec 5;7(1):16953. doi: 10.1038/s41598-017-17166-8.

34.

Improvement of the Solubility and Intestinal Absorption of Curcumin by N-Acyl Taurates and Elucidation of the Absorption-Enhancing Mechanisms.

Li X, Kawamura A, Sato Y, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Biol Pharm Bull. 2017;40(12):2175-2182. doi: 10.1248/bpb.b17-00581.

35.

Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement.

Li X, Uehara S, Sawangrat K, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Int J Pharm. 2018 Jan 15;535(1-2):340-349. doi: 10.1016/j.ijpharm.2017.11.032. Epub 2017 Nov 20. Erratum in: Int J Pharm. 2018 Apr 25;541(1-2):261.

PMID:
29157961
36.

Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles.

Kimura S, Kiriyama A, Araki K, Yoshizumi M, Enomura M, Inoue D, Furubayashi T, Yutani R, Teraoka R, Tanaka A, Kusamori K, Katsumi H, Yamamoto A, Iga K, Sakane T.

Eur J Pharm Biopharm. 2018 Jan;122:1-5. doi: 10.1016/j.ejpb.2017.09.017. Epub 2017 Oct 5.

PMID:
28987513
37.

The detectability of the pretreatment EGFR T790M mutations in lung adenocarcinoma using CAST-PCR and digital PCR.

Tatematsu T, Okuda K, Suzuki A, Oda R, Sakane T, Kawano O, Haneda H, Moriyama S, Sasaki H, Nakanishi R.

J Thorac Dis. 2017 Aug;9(8):2397-2403. doi: 10.21037/jtd.2017.07.02.

38.

Correction for Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.

Takayama K, Mori K, Tanaka A, Nomura E, Sohma Y, Mori M, Taguchi A, Taniguchi A, Sakane T, Yamamoto A, Minamino N, Miyazato M, Kangawa K, Hayashi Y.

J Med Chem. 2017 Sep 14;60(17):7613. doi: 10.1021/acs.jmedchem.7b01148. Epub 2017 Aug 18. No abstract available.

PMID:
28820261
39.

Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis.

Katsumi H, Tanaka Y, Hitomi K, Liu S, Quan YS, Kamiyama F, Sakane T, Yamamoto A.

Pharmaceutics. 2017 Aug 17;9(3). pii: E29. doi: 10.3390/pharmaceutics9030029.

40.

Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases.

Yamashita S, Katsumi H, Hibino N, Isobe Y, Yagi Y, Kusamori K, Sakane T, Yamamoto A.

J Control Release. 2017 Sep 28;262:10-17. doi: 10.1016/j.jconrel.2017.07.018. Epub 2017 Jul 11.

PMID:
28710004
41.

Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinoma.

Suzuki A, Okuda K, Yano M, Oda R, Sakane T, Kawano O, Haneda H, Moriyama S, Nakanishi M, Nakanishi R.

Oncol Lett. 2017 Jul;14(1):891-898. doi: 10.3892/ol.2017.6216. Epub 2017 May 19.

42.

Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma.

Okuda K, Oda R, Suzuki A, Sakane T, Kawano O, Haneda H, Moriyama S, Nakanishi R.

J Thorac Dis. 2017 May;9(5):1295-1302. doi: 10.21037/jtd.2017.03.167.

43.

Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.

Takayama K, Mori K, Tanaka A, Nomura E, Sohma Y, Mori M, Taguchi A, Taniguchi A, Sakane T, Yamamoto A, Minamino N, Miyazato M, Kangawa K, Hayashi Y.

J Med Chem. 2017 Jun 22;60(12):5228-5234. doi: 10.1021/acs.jmedchem.7b00694. Epub 2017 Jun 2. Erratum in: J Med Chem. 2017 Sep 14;60(17):7613.

PMID:
28548497
44.

Nasal Drug Absorption from Powder Formulations: Effect of Fluid Volume Changes on the Mucosal Surface.

Tanaka A, Furubayashi T, Enomura Y, Hori T, Shimomura R, Maeda C, Kimura S, Inoue D, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Biol Pharm Bull. 2017;40(2):212-219. doi: 10.1248/bpb.b16-00787.

45.

The Enhancement of Nasal Drug Absorption From Powder Formulations by the Addition of Sodium Carboxymethyl Cellulose.

Tanaka A, Furubayashi T, Yamasaki H, Takano K, Kawakami M, Kimura S, Inoue D, Katsumi H, Sakane T, Yamamoto A.

IEEE Trans Nanobioscience. 2016 Dec;15(8):798-803. doi: 10.1109/TNB.2016.2612682. Epub 2017 Jan 4.

PMID:
28060709
46.

Enhanced oral delivery of alendronate by sucrose fatty acids esters in rats and their absorption-enhancing mechanisms.

Alama T, Katayama H, Hirai S, Ono S, Kajiyama A, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Int J Pharm. 2016 Dec 30;515(1-2):476-489. doi: 10.1016/j.ijpharm.2016.10.046. Epub 2016 Oct 25.

PMID:
27793710
47.

Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC).

Tanaka A, Furubayashi T, Tomisaki M, Kawakami M, Kimura S, Inoue D, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Eur J Pharm Sci. 2017 Jan 1;96:284-289. doi: 10.1016/j.ejps.2016.09.028. Epub 2016 Sep 21.

PMID:
27664332
48.

Effects of 2 Polyoxyethylene Alkyl Ethers on the Function of Intestinal P-glycoprotein and Their Inhibitory Mechanisms.

Zhao W, Alama T, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

J Pharm Sci. 2016 Dec;105(12):3668-3679. doi: 10.1016/j.xphs.2016.09.002. Epub 2016 Oct 19.

PMID:
27771052
49.

Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms.

Nakaya Y, Takaya M, Hinatsu Y, Alama T, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

J Pharm Sci. 2016 Dec;105(12):3680-3690. doi: 10.1016/j.xphs.2016.09.004. Epub 2016 Oct 19.

PMID:
27771051
50.

Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption.

Tanaka A, Furubayashi T, Matsushita A, Inoue D, Kimura S, Katsumi H, Sakane T, Yamamoto A.

PLoS One. 2016 Sep 6;11(9):e0159150. doi: 10.1371/journal.pone.0159150. eCollection 2016.

Supplemental Content

Loading ...
Support Center